全球领先的数字病理软件供应商Proscia近日宣布，成功在C+轮融资中募集到900万美元，使得该轮融资的总金额达到了4600万美元。此轮融资由Highline Capital Management和Triangle Peak Partners共同领投，同时获得了包括Alpha Intelligence Capital、Scale Venture Partners以及Hitachi Ventures等现有投资者的积极参与。
这笔新资金的注入将主要用于推动Proscia的商业扩张，以及深化其在生命科学和诊断实验室领域的人工智能应用程序的研发。Proscia的AI驱动病理学云平台以其创新技术在业界备受瞩目，它通过人工智能技术优化病理学研究和诊断流程，提高了病理学家的工作效率和精确度。
随着这笔资金的到位，Proscia有望进一步提升其在数字病理学市场的领先地位，推动病理学研究的数字化转型，并为全球的医疗和科研机构提供更为智能、高效的解决方案。这一发展不仅将影响病理学领域，也将对整个生命科学行业产生深远影响，加快疾病诊断和治疗的进步。
英语如下：
**News Title:** “AI Pathology Platform Proscia Secures $9 Million in C+ Funding Round, Accelerating Digital Healthcare”
**Keywords:** Proscia, AI Pathology, $9 Million Funding
**News Content:**
Pathology AI cloud platform Proscia has recently announced the completion of a $9 million C+ funding round, bringing the total raised in this round to $46 million. The round was co-led by Highline Capital Management and Triangle Peak Partners, with strong participation from existing investors, including Alpha Intelligence Capital, Scale Venture Partners, and Hitachi Ventures.
The fresh injection of capital will primarily fuel Proscia’s commercial expansion and further development of its artificial intelligence (AI) applications in the life sciences and diagnostic laboratory sectors. Proscia’s AI-powered pathology cloud platform has garnered industry attention for its innovative technology, which optimizes pathology research and diagnostic workflows, enhancing pathologists’ efficiency and accuracy.
With this funding, Proscia is poised to solidify its leadership in the digital pathology market, propel the digital transformation of pathology research, and offer smarter, more efficient solutions to healthcare and research institutions worldwide. This development not only impacts the field of pathology but is also expected to have a profound effect on the broader life sciences industry, accelerating advancements in disease diagnosis and treatment.
【来源】https://venturebeat.com/ai/proscias-46m-series-c-propels-ai-driven-pathology-into-the-mainstream/
Views: 1